About Jell Pharmaceuticals Private Limited
Data last updated:
Jell Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the home care and cleaning products segment of the FMCG sector. It was incorporated on 31 August 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U23200MH1994PTC080671. Its GSTIN is 27AABCJ2207L1ZO (Maharashtra). The company holds 4 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors Sanjay Chandrakant Mehta (Whole-Time Director) and Chirag Chandrakant Mehta (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at B – 6/A Sidhapura Industrial Estate L.B. Shastri Marg Ghatkopar (W), Mumbai, Maharashtra, India – 400086.
As per the financials filed for FY 2023, the company reported a revenue of ₹459 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹12.56 Cr (net margin 2.7%) and EBITDA of ₹23.76 Cr (EBITDA margin 5.2%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 17% over five years.
The company has about 222 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Jell Pharmaceuticals. As per MCA filings, the company has open charges of ₹67.5 Cr on record. The company has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹18.3 Lakh; the latest was in March 2022. Its 10 peer companies in the FMCG industry (Home Care Products, Personal Care and Skin Care, Pharmaceuticals) are compared by revenue, 5 larger and 5 smaller; the largest is Aarey Drugs and Pharmaceuticals Limited with revenue of ₹483.76 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website jellpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressB – 6/A Sidhapura Industrial Estate L.B. Shastri Marg Ghatkopar (W), Mumbai, Maharashtra, India – 400086
- IndustryFMCG, Home Care & Cleaning Products, Personal Care & Skincare Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Jell Pharmaceuticals Private Limited
Jell Pharmaceuticals operates one associated brand: Jell Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers contract-based drug manufacturing and marketing services in pharmaceuticals. | jellpharma.com |
Business Activity of Jell Pharmaceuticals Private Limited
The main business activity of Jell Pharmaceuticals is manufacturing. In detail, this covers coke and refined petroleum products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C5 | Coke and refined petroleum products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Jell Pharmaceuticals Private Limited FY 2024 filings available
Jell Pharmaceuticals Private Limited reported revenue of ₹459 Cr (up 8% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Jell Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 8% growth in the latest year. EBITDA rose 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Jell Pharmaceuticals Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹459 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹23.76 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹12.56 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Jell Pharmaceuticals Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Jell Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Jell Pharmaceuticals Private Limited
Jell Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Chandrakant Mehta Also directs: Golden Oak Impex LLP, Dhaval Chem Private Limited, Sunil Paint and Varnishers Company Private Limited and 1 more | Whole-Time Director | 31 Aug 1994 | 32 Years 1 Months | Current |
| Chirag Chandrakant Mehta | Whole-Time Director | 31 Aug 1994 | 32 Years 1 Months | Current |
Peer Comparison of Jell Pharmaceuticals Private Limited
Jell Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the FMCG industry (Home Care Products, Personal Care and Skin Care, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aarey Drugs and Pharmaceuticals Limited Listed | ₹483.76 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Thane, Maharashtra, India |
| Karnataka Antibiotics and Pharmaceuticals Limited | ₹479.24 Cr (FY 2022) | •••• | •••• | 11.0% | •••• | Bangalore, Karnataka, India |
| Cachet Pharmaceuticals Private Limited | ₹478.02 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Patna, Bihar, India |
| Supermax Personal Care Private Limited | ₹472.17 Cr (FY 2022) | •••• | •••• | 8.0% | •••• | Thane, Maharashtra, India |
| Amrutanjan Health Care Limited Listed | ₹469.5 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Chennai, Tamil Nadu, India |
| Jell Pharmaceuticals Private Limited this company | ₹459 Cr (FY 2023) | •••• | •••• | 8.0% | •••• | Mumbai, Maharashtra, India |
| Biophore India Pharmaceuticals Private Limited | ₹457 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | Hyderabad, Telangana, India |
| Idam Natural Wellness Private Limited | ₹456.69 Cr (FY 2024) | •••• | •••• | 146.0% | •••• | Mumbai, Maharashtra, India |
| Fredun Pharmaceuticals Ltd Listed | ₹456.27 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | Mumbai, Maharashtra, India |
| Yutika Natural Private Limited | ₹454.63 Cr (FY 2025) | •••• | •••• | 23.0% | •••• | Sojat, Rajasthan, India |
| Hab Pharmaceuticals and Research Limited | ₹448.72 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Jell Pharmaceuticals by revenue in the FMCG industry (Home Care Products, Personal Care and Skin Care, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Jell Pharmaceuticals Private Limited
Jell Pharmaceuticals Private Limited is audited by B. M. PANDYA & COMPANY for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| B. M. PANDYA & COMPANY | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Jell Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Jell Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jul 2024 | Others | ₹1 Cr | Open |
| 14 Dec 2011 | Bank of India | ₹3 Cr | Open |
| 25 Jan 2007 | Bank of India | ₹63.5 Cr | Open |
Total charge records: 3 View all charges
Deals & Funding of Jell Pharmaceuticals Private Limited
Jell Pharmaceuticals Private Limited has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹18.3 Lakh; the latest was in March 2022.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Chandrakant S Mehta HUF, 2 individuals |
| May 2015 | Funding round | ₹10 Lakh | Investors: 4 individuals |
| Mar 2014 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Mar 2007 | Funding round | ₹8.3 Lakh | Investors: 4 individuals |
Full deal history
All 4 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Employees and EPFO Compliance at Jell Pharmaceuticals Private Limited
Jell Pharmaceuticals Private Limited has a workforce of 222 employees as of Feb 28, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Jell Pharmaceuticals Private Limited
Jell Pharmaceuticals Private Limited has 5 board changes on record since 1994: 2 appointments and 3 cessations. The latest: Chirag Chandrakant Mehta ceased to be Director on 22 Nov 2018.
Credit Ratings, Litigation & Regulatory Alerts for Jell Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Jell Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Jell Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Jell Pharmaceuticals Private Limited
Jell Pharmaceuticals has 4 GST registrations: 4 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCJ2207L1ZO | Maharashtra | Active | 01 Jul 2017 |
| 27AABCJ2207L2ZN | Maharashtra | Active | 11 Jul 2017 |
| 26AABCJ2207L1ZQ | Dadra and Nagar Haveli and Daman and Diu | Active | 01 Jul 2017 |
| 26AABCJ2207L2ZP | Dadra and Nagar Haveli and Daman and Diu | Active | 01 Sep 2024 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Jell Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Jell Pharmaceuticals Private Limited
Frequently Asked Questions about Jell Pharmaceuticals Private Limited
Jell Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in home care and cleaning products, within the FMCG industry. It was incorporated on 31 August 1994 (32+ years old) and is registered under CIN U23200MH1994PTC080671.
Jell Pharmaceuticals reported revenue of ₹459 Cr for FY 2023 (up 8% YoY).
Jell Pharmaceuticals has 2 current directors:
- Sanjay Chandrakant Mehta - Whole-Time Director
- Chirag Chandrakant Mehta - Whole-Time Director
Jell Pharmaceuticals reported a net profit of ₹12.56 Cr (net margin 2.7%) and EBITDA of ₹23.76 Cr (EBITDA margin 5.2%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Jell Pharmaceuticals is 23% over three years and 17% over five years. In the latest year (FY 2023) revenue rose 8%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Jell Pharmaceuticals is 27AABCJ2207L1ZO, registered in Maharashtra. The company has 4 GST registrations in all, of which 4 are active. Other active GSTINs include 27AABCJ2207L2ZN (Maharashtra), 26AABCJ2207L1ZQ (Dadra and Nagar Haveli and Daman and Diu), 26AABCJ2207L2ZP (Dadra and Nagar Haveli and Daman and Diu).
The CIN (Corporate Identification Number) of Jell Pharmaceuticals is U23200MH1994PTC080671. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jell Pharmaceuticals was incorporated on 31 August 1994, making it 32+ years old. It is registered with the Registrar of Companies, Mumbai.
Jell Pharmaceuticals has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹18.3 Lakh; the latest was in March 2022.
The peers of Jell Pharmaceuticals by revenue are Aarey Drugs and Pharmaceuticals Limited, Karnataka Antibiotics and Pharmaceuticals Limited, Cachet Pharmaceuticals Private Limited, Supermax Personal Care Private Limited, Amrutanjan Health Care Limited and 5 more, all in the FMCG industry (Home Care Products, Personal Care and Skin Care, Pharmaceuticals).
Chirag Chandrakant Mehta ceased to be Director on 22 Nov 2018. Parag Chandrakant Mehta ceased to be Director on 22 Nov 2018. Sanjay Chandrakant Mehta ceased to be Director on 22 Nov 2018. Jell Pharmaceuticals has 5 board changes on record in total.